Embecta Corp
EMBC Small CapHealthcare · Medical Instruments & Supplies
Aktualisiert: Apr 5, 2026, 17:43 UTC
$8.85
+0.68% heute
52W: $8.47 – $15.55
52W Low: $8.47
Position: 5.4%
52W High: $15.55
Kennzahlen
P/E Ratio
3.75x
Kurs/Gewinn-Verhältnis
Forward P/E
3.07x
Erwartetes KGV
P/S Ratio
0.49x
Kurs/Umsatz-Verhältnis
EV/EBITDA
4.73x
Unternehmenswert/EBITDA
Dividendenrendite
679%
Jährl. Dividendenrendite
Market Cap
$524.1M
Marktkapitalisierung
Umsatzwachstum
-0.3%
YoY Umsatzwachstum
Gewinnmarge
12.92%
Nettomarge
ROE
—
Eigenkapitalrendite
Beta
1.1
Marktsensitivität
Short Interest
11.31%
% der Aktien leerverkauft
Ø Volumen
846,154
Durchschn. Tagesvolumen
Bewertungs-Analyse
Signal
Unterbewertet
vs. S&P 500 Ø KGV (24.7x)
Analysten-Konsens
None
3 Analysten
Ø Kursziel
$16.67
+88.32% Upside
Kursziel Spanne
$11.00 – $25.00
Über das Unternehmen
Embecta Corp., a medical device company, provides solutions to improve the health and wellbeing of people living with diabetes in the United States and internationally. The company's products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient's diabetes. It primarily sells its products to wholesalers and distributors. The company was formerly known as Berra Newco, Inc. Embecta Corp. was founded in 1924 and is headquartered in Parsippany, New Jersey.
Sektor: Healthcare Branche: Medical Instruments & Supplies Land: United States Mitarbeiter: 1,850 Börse: NMS
Trading-Daten
50-Day MA:
$9.83
200-Day MA:
$11.97
Volumen:
929,565
Ø Volumen:
846,154
Short Ratio:
6.53
Kurs/Buchwert:
—
Verschuldung/EK:
—
Free Cash Flow:
$188.9M
💵 Dividenden-Info
Dividendenrendite
679%
Jährl. Dividende
$0.60
Ausschüttungsquote
25.42%
Ähnliche Aktien aus dem Sektor
Wo kann ich Embecta Corp kaufen?
Vergleiche die besten Broker — niedrige Gebühren, seriöse Anbieter, reguliert.